March 23, 2021 Update0

Do you know how many joints are in your body? Chances are you only know the joints that give you pain or fatigue. The human body has over 200 joints and many patients over the age of 55 experience joint pain in 4 to 8 isolated locations of their body. As the cells that surround the joints and tendons break down due to age and environmental factors, pain and range of  movement are affected. Regenerative medicine targets joints and tendons on a cellular level to repair, restore and renew the supporting cells and tissues that allow these joints and tendons to work properly.

Knees, tennis elbow, golfers elbow, shoulders and ankles are widely affected by the years of athletic performance, environmental factors and daily use of our joints and tendons.

Our bodies break down starts on a cellular level, that is why the treatment course should start on a cellular level. Instead of treating the symptoms we treat the root of the cause which is the breakdown of the supporting tissues that are needed for full range of movement and a pain-free lifestyle.

Contact us today for a Complimentary Consultation with Board Certified Physician, Dr. Jeffrey Baker.

(Patient: Male, 20 year career professional Soccer athlete & National Trainer. Injury: ACL tear. Treatment: Stem Cell Therapy Injections.)


March 10, 2021 Update

Researchers have investigated Mesenchymal Stem Cells (MSCs) in COVID-19 treatment to repair lung damage associated with COVID-19. Currently, there are no treatment options for COVID-19 related lung damage. Severely damaged lungs may require replacement through a transplant. In other cases, damage may heal slowly over time, although some damage may be permanent.

However, stem cell therapy is a promising option that may be able to not only heal damage but to regenerate lung tissue. Many stem cell trials are currently underway involving COVID-19 patients to determine the efficacy and value of this treatment.

COVID-19 may cause your immune system to overreact and over-release cytokines. Unable to stop, the resulting cytokine storm may cause damaging fluid to enter your lungs and harm or stop your breathing. It’s theorized that immunomodulatory MSCs may be able to normalize immune system function, quell the cytokine storm that affects the lungs, and help heal the damage caused.

MSCs may help fight inflammation, such as lowering the amount of the inflammation marker C-reactive protein and raising the levels of anti-inflammatory protein IL-10. Additional benefits of MSCs may include preventing pulmonary fibrosis and guarding alveolar epithelial cells.

Mesenchymal stem cells derived from umbilical cord tissue could help treat ARDS in COVID-19 patients, according to results of a Phase I/IIa clinical trial published by University of Miami researchers.

The trial’s primary purpose was safety, and while both the treatment and control groups received the best standard of care, there were no differences reported in serious adverse events between the group receiving infusions with 100 million umbilical cord MSCs and the group receiving a vehicle, and no adverse events observed related to infusion. The safety findings are in line with a Phase I study led by Chinese researchers from the National Clinical Research Center for Infectious Diseases, which showed higher and more frequent infusions of umbilical cord-derived MSCs to be safe in moderate to severe COVID-19 patients with pulmonary distress.


Copyright by Optimize Health Miami. All rights reserved.